• 名称：Vipadenant (BIIB-014)
• 简介：Vipadenant, also known as BIIB014, CEB-4520, is a potent, selective and orally available adenosine A2A receptor antagonist under development for Parkinson's disease. Vipadenant demonstrates strong oral activity in commonly used models of Parkinson's disease.
• CASNO：442908-10-3
• 分子式：C16H15N7O?
• 分子量：321.344
• SMILES：NC1=NC(C2=CC=CO2)=C(N=NN3CC4=CC=C(N)C(C)=C4)C3=N1
• 保持条件：at -20°C 3 years Powder
• 同名：BIIB014, BIIB-014, BIIB 014, CEB-4520, CEB 4520, CEB4520, V-2006, V2006, V 2006, VER-11135, VER-A00-11, VER-A00049, VER-ADO-49, Vipadenant
• 纯度：>98%
• 应用：A2A receptor antagonist
• 作用机制：Antagonist